Targeting HIV-1 transcription factor binding sites using CRISPR/Cas9 to permanently deactivate latent provirus

被引：0
|
作者：
Chung, Cheng-Han [1 ,2 ]
Allen, Alexander G. [1 ,2 ]
Atkins, Andrew K. [1 ,2 ]
Costello, Robert [1 ,2 ]
Sullivan, Neil T. [1 ,2 ]
Nonnemacher, Michael R. [1 ,2 ,3 ]
Dampier, Will [1 ,2 ,4 ]
Wigdahl, Brian [1 ,2 ,3 ]
机构：
[1] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA
[2] Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Ctr Mol Virol & Translat Neurosci, Philadelphia, PA 19104 USA
[3] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[4] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA
来源：
JOURNAL OF NEUROVIROLOGY | 2019年 / 25卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P30
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [31] Reduction of Complement Factor B using CRISPR/Cas9
    Adnan, Mutayyaba
    Latuszck, Adrianna
    Sun, Aixu
    Chen, Henry
    Brown, Heather
    Hartford, Suzanne
    Hu, Ying
    Cao, Jingtai
    Sagdullaev, Botir T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [32] Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics
    Dampier, Will
    Sullivan, Neil T.
    Mell, Joshua Chang
    Pirrone, Vanessa
    Ehrlich, Garth D.
    Chung, Cheng-Han
    Allen, Alexander G.
    DeSimone, Mathew
    Zhong, Wen
    Kercher, Katherine
    Passic, Shendra
    Williams, Jean W.
    Szep, Zsofia
    Khalili, Kamel
    Jacobson, Jeffrey M.
    Nonnemacher, Michael R.
    Wigdahl, Brian
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (11) : 950 - 960
  • [33] A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes
    Huang, Zaohua
    Nair, Madahavan
    SCIENTIFIC REPORTS, 2017, 7
  • [34] In vitro validation of CRISPR-Cas9 mediated targeting of transgene integration sites to excise HIV-1 sequences from HIV-1 Tg rat
    Luongo, F. P.
    Dabrowski, K.
    Huang, W.
    Mack, M.
    Mactutus, C. F.
    Booze, R. M.
    Chang, S. L.
    Kaminski, R.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2019, 14 (02) : 344 - 344
  • [35] Targeting hepatitis B virus cccDNA using CRISPR/Cas9
    Kennedy, Edward M.
    Kornepati, Anand V. R.
    Cullen, Bryan R.
    ANTIVIRAL RESEARCH, 2015, 123 : 188 - 192
  • [36] Tissue-specific gene targeting using CRISPR/Cas9
    Ablain, J.
    Zon, L. I.
    ZEBRAFISH: GENETICS, GENOMICS, AND TRANSCRIPTOMICS, 4TH EDITION, 2016, 135 : 189 - 202
  • [37] Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1
    Mudit Tyagi
    Sergey Iordanskiy
    Tatyana Ammosova
    Namita Kumari
    Kahli Smith
    Denitra Breuer
    Andrey V Ilatovskiy
    Yasemin Saygideğer Kont
    Andrey Ivanov
    Aykut Üren
    Dmytro Kovalskyy
    Michael Petukhov
    Fatah Kashanchi
    Sergei Nekhai
    Retrovirology, 12
  • [38] Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1
    Tyagi, Mudit
    Iordanskiy, Sergey
    Ammosova, Tatyana
    Kumari, Namita
    Smith, Kahli
    Breuer, Denitra
    Ilatovskiy, Andrey V.
    Kont, Yasemin Saygideger
    Ivanov, Andrey
    Ueren, Aykut
    Kovalskyy, Dmytro
    Petukhov, Michael
    Kashanchi, Fatah
    Nekhai, Sergei
    RETROVIROLOGY, 2015, 12 : 1 - 17
  • [39] Incorporating CCL2-GPI into Gesicles to Enhance the Efficacy of CRISPR/Cas9 for Inactivating the HIV Provirus
    Campbell, Lee A.
    Richie, Christopher T.
    Fortuno, Lowella V.
    Harvey, Brandon K.
    MOLECULAR THERAPY, 2018, 26 (05) : 423 - 423
  • [40] The effect of CTCF binding sites destruction by CRISPR/Cas9 on transcription of metallothionein gene family in liver hepatocellular carcinoma
    Gong, Wenjing
    Liu, Youde
    Qu, Huajun
    Liu, Aina
    Sun, Ping
    Wang, Xiumei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 510 (04) : 530 - 538
12345